Yan-yan Yu - Publications

One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C.

Journal: World journal of clinical cases

Published: April 13, 2022

240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C.

Journal: Journal of viral hepatitis

Published: March 17, 2022

USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells.

Journal: Journal of clinical and translational hepatology

Published: February 06, 2022

Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 13, 2021

Human immune repertoire in hepatitis B virus infection.

Journal: World journal of gastroenterology

Published: January 25, 2021

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks.

Journal: World journal of clinical cases

Published: December 17, 2020

Early renal injury indicators can help evaluate renal injury in patients with chronic hepatitis B with long-term nucleos(t)ide therapy.

Journal: World journal of clinical cases

Published: September 23, 2020

Management of chronic liver diseases and cirrhosis: current status and future directions.

Journal: Chinese medical journal

Published: September 14, 2020

Human genetic susceptibility to hepatitis B virus infection.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: May 30, 2020

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48.

Journal: Medicine

Published: August 16, 2019

Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.

Journal: Respiratory research

Published: January 03, 2019

Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus.

Journal: BMC microbiology

Published: November 10, 2017